Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 59

Sort by

Sort Order Select

Journal Articles

Abstract 403: Characterization of PROTACs for targeting tissue transglutaminase 2 (TG2) in cancer

Andres Felipe Valdivia, Purav Vagadia, Natalia Masnica, Joshua Li Zhu, Vanessa Hernandez, Ana Maria Isac, Gary Schiltz, Daniela Matei

Cancer Res (2025) 85 (8_Supplement_1): 403.

https://doi.org/10.1158/1538-7445.AM2025-403

Published: 21 April 2025

View articletitled, Abstract 403: Characterization of PROTACs for targeting tissue transglutaminase 2 (TG2) in cancer

Journal Articles

Abstract 5805: Immunomodulatory effects of TG2 in the ovarian cancer tumor microenvironment

Hao Huang, Ping Xie, Ujin Kim, Longzhen Song, Jianjun Wei, Daniela Matei, Bin Zhang

Cancer Res (2025) 85 (8_Supplement_1): 5805.

https://doi.org/10.1158/1538-7445.AM2025-5805

Published: 21 April 2025

View articletitled, Abstract 5805: Immunomodulatory effects of TG2 in the ovarian cancer tumor microenvironment

Journal Articles

Abstract 1536: Unsaturated fatty acids promote cell cycle progression and proliferation of platinum resistant ovarian cancer cells

Ana Maria Isac, Andres Valdivia, Guangyuan Zhao, Yinu Wang, Jian-Jun Wei, Sandra Orsulic, Daniela Matei

Cancer Res (2025) 85 (8_Supplement_1): 1536.

https://doi.org/10.1158/1538-7445.AM2025-1536

Published: 21 April 2025

View articletitled, Abstract 1536: Unsaturated fatty acids promote cell cycle progression and proliferation of platinum resistant ovarian cancer cells

Journal Articles

Abstract 3867: Small molecule inhibitors targeting TG2 in ovarian cancer and identification of drug escape pathways

Monica Tudor, Cristian Munteanu, Gabriela Chiritoiu, Stefana Orobeti, Alexandra Bran, Florin Jipa, Felix Sima, Gary E. Schiltz, Daniela Matei, Livia Elena Sima

Cancer Res (2025) 85 (8_Supplement_1): 3867.

https://doi.org/10.1158/1538-7445.AM2025-3867

Published: 21 April 2025

View articletitled, Abstract 3867: Small molecule inhibitors targeting TG2 in ovarian cancer and identification of drug escape pathways

Journal Articles

Abstract 4410: Targeting MEIS2 in platinum resistant ovarian cancer

Yinu Wang, Natalia Obrochta, Junzui Li, Daniela Matei

Cancer Res (2025) 85 (8_Supplement_1): 4410.

https://doi.org/10.1158/1538-7445.AM2025-4410

Published: 21 April 2025

View articletitled, Abstract 4410: Targeting MEIS2 in platinum resistant ovarian cancer

Journal Articles

Abstract 4101: Blood based biomarkers of DNA methylation associated with platinum resistance in high grade serous ovarian cancer

Daniela Matei, Horacio Cardenas, Elnaz Abbasi Farid, Zhen Fu, Collin M. Coon, Adam Vieth, Kenneth P. Nephew

Cancer Res (2025) 85 (8_Supplement_1): 4101.

https://doi.org/10.1158/1538-7445.AM2025-4101

Published: 21 April 2025

View articletitled, Abstract 4101: Blood based biomarkers of DNA methylation associated with platinum resistance in high grade serous ovarian cancer

Journal Articles

Abstract 7047: Comparative analysis of transcriptomic and immunological profiles in treatment-naïve black and non-Hispanic White women with high-grade serous ovarian cancer

Hao Huang, Russel Keathley, Ujin Kim Kim, Horacio Cardenas, Ping Xie, Jianjun Wei, Guangyuan Zhao, Emma L. Barber, Ernst Lengyel, Kenneth P. Nephew, Victoria Bae-Jump, Bin Zhang, Daniela Matei

Cancer Res (2024) 84 (6_Supplement): 7047.

https://doi.org/10.1158/1538-7445.AM2024-7047

Published: 22 March 2024

View articletitled, Abstract 7047: Comparative analysis of transcriptomic and immunological profiles in treatment-naïve black and non-Hispanic White women with high-grade serous ovarian cancer

Journal Articles

Abstract 2580: Targeting chromatin in ovarian cancer stem cells

Yinu Wang, Jane Frederick, Yaqi Zhang, Elizabeth Thomas Bartom, Greta Bauer, Edward Tanner, Vadim Backman, Daniela Matei

Cancer Res (2024) 84 (6_Supplement): 2580.

https://doi.org/10.1158/1538-7445.AM2024-2580

Published: 22 March 2024

View articletitled, Abstract 2580: Targeting chromatin in ovarian cancer stem cells

Journal Articles

Abstract 443: Unsaturated fatty acids promote cell cycle progression and proliferation of platinum resistant ovarian cancer cells

Ana Maria Isac, Guangyuan Zhao, Horacio Cardenas, Daniela Matei

Cancer Res (2024) 84 (6_Supplement): 443.

https://doi.org/10.1158/1538-7445.AM2024-443

Published: 22 March 2024

View articletitled, Abstract 443: Unsaturated fatty acids promote cell cycle progression and proliferation of platinum resistant ovarian cancer cells

Journal Articles

Abstract IA018: Epigenome targeting in ovarian cancer: preclinical models to clinic

Daniela Matei

Cancer Res (2024) 84 (5_Supplement_2): IA018.

https://doi.org/10.1158/1538-7445.OVARIAN23-IA018

Published: 04 March 2024

View articletitled, Abstract IA018: Epigenome targeting in ovarian cancer: preclinical models to clinic

Journal Articles

Abstract A036: Nanoparticle targeting in platinum-resistant ovarian cancer reveals dual axis of therapeutic vulnerability involving cholesterol uptake and cell redox balance

Yinu Wang, Andrea Calvert, Cardenas Horacio, Fukai Chen, Russell Keathley, Ji-Xin Chen, Shad Thaxton, Daniela Matei

Cancer Res (2024) 84 (5_Supplement_2): A036.

https://doi.org/10.1158/1538-7445.OVARIAN23-A036

Published: 04 March 2024

View articletitled, Abstract A036: Nanoparticle targeting in platinum-resistant ovarian cancer reveals dual axis of therapeutic vulnerability involving cholesterol uptake and cell redox balance

Journal Articles

Abstract CT056: A multicenter, open-label phase 1/2 trial evaluating the safety, tolerability, and efficacy of MORAb-202, a folate-receptor-alpha-targeting antibody-drug conjugate in patients with selected tumor types

Robert Wenham, Sharad Ghamande, Vicky Makker, June Hou, Linda Duska, Daniela Matei, Manali Bhave, Rachael Scott, Natalyn Hawk, Tingting Song, Deborah K. Armstrong

Cancer Res (2023) 83 (8_Supplement): CT056.

https://doi.org/10.1158/1538-7445.AM2023-CT056

Published: 14 April 2023

View articletitled, Abstract CT056: A multicenter, open-label phase 1/2 trial evaluating the safety, tolerability, and efficacy of MORAb-202, a folate-receptor-alpha-targeting antibody-drug conjugate in patients with selected tumor types

Journal Articles

Abstract 6068: Methylomic, transcriptomic and immune profiles of high grade serous ovarian cancer among Black and non-Hispanic White women

Hao Huang, Russell Keathley, Ping Xie, JianJun Wei, Ernst Lengyel, Bin Zhang, Daniela Matei

Cancer Res (2023) 83 (7_Supplement): 6068.

https://doi.org/10.1158/1538-7445.AM2023-6068

Published: 04 April 2023

View articletitled, Abstract 6068: Methylomic, transcriptomic and immune profiles of high grade serous ovarian cancer among Black and non-Hispanic White women

Journal Articles

Abstract 2499: Complement activation at the interface between cancer cells and adipocytes

Andres Felipe Valdivia, Hao Huang, Horacio Cardenas, Aloysius Klingelhutz, Daniela Matei

Cancer Res (2023) 83 (7_Supplement): 2499.

https://doi.org/10.1158/1538-7445.AM2023-2499

Published: 04 April 2023

View articletitled, Abstract 2499: Complement activation at the interface between cancer cells and adipocytes

Journal Articles

Abstract 5797: NTX301, a novel DNA hypomethylating agent, targets lipid metabolism in ovarian cancer

Yinu Wang, Xiaolei Situ, Horacio Cardenas, Daniela Matei, Ellie Siu, Sayedabdulrazzaq A. Alhunayan

Cancer Res (2023) 83 (7_Supplement): 5797.

https://doi.org/10.1158/1538-7445.AM2023-5797

Published: 04 April 2023

View articletitled, Abstract 5797: NTX301, a novel DNA hypomethylating agent, targets lipid metabolism in ovarian cancer

Journal Articles

Abstract 5811: Ovarian cancer cell fate is regulated by the balance between saturated and unsaturated fatty acids

Guangyuan Zhao, Yuying Tan, Horacio Cardenas, David Vayngart, Yinu Wang, Christina Ferreira, Ji-Xin Cheng, Daniela Matei

Cancer Res (2022) 82 (12_Supplement): 5811.

https://doi.org/10.1158/1538-7445.AM2022-5811

Published: 15 June 2022

View articletitled, Abstract 5811: Ovarian cancer cell fate is regulated by the balance between saturated and unsaturated fatty acids

Journal Articles

Abstract 5359: M6A regulated NNMT mediates resistance to platinum in ovarian cancer

Hao Huang, Guangyuan Zhao, Andres Felipe Valdivia, Horacio Cardenas, Yinu Wang, Daniela Daniela Matei

Cancer Res (2022) 82 (12_Supplement): 5359.

https://doi.org/10.1158/1538-7445.AM2022-5359

Published: 15 June 2022

View articletitled, Abstract 5359: M6A regulated NNMT mediates resistance to platinum in ovarian cancer

Journal Articles

Abstract 2978: E2F1 regulates cell competition, increase proliferation and inhibits chemotherapy resistance in cancer cells

Andres Felipe Valdivia, Matthew Cowan, Guangyuan Zhao, Horacio Cardenas, Daniela Matei

Cancer Res (2022) 82 (12_Supplement): 2978.

https://doi.org/10.1158/1538-7445.AM2022-2978

Published: 15 June 2022

View articletitled, Abstract 2978: E2F1 regulates cell competition, increase proliferation and inhibits chemotherapy resistance in cancer cells

Journal Articles

Abstract 995: Tissue transglutaminase regulates integrin-linked kinase and beta-catenin signaling in ovarian cancer cells

Salvatore Condello, Rula Atwani, Daniela Matei

Cancer Res (2022) 82 (12_Supplement): 995.

https://doi.org/10.1158/1538-7445.AM2022-995

Published: 15 June 2022

View articletitled, Abstract 995: Tissue transglutaminase regulates integrin-linked kinase and beta-catenin signaling in ovarian cancer cells

Journal Articles

Abstract 5467: NTX301 targets platinum resistant ovarian cancer

Yinu Wang, Xiaolei Situ, Horacio Cardenas, Daniela Matei

Cancer Res (2022) 82 (12_Supplement): 5467.

https://doi.org/10.1158/1538-7445.AM2022-5467

Published: 15 June 2022

View articletitled, Abstract 5467: NTX301 targets platinum resistant ovarian cancer

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 403: Characterization of PROTACs for targeting tissue transglutaminase 2 (TG2) in cancer

Abstract 5805: Immunomodulatory effects of TG2 in the ovarian cancer tumor microenvironment

Abstract 1536: Unsaturated fatty acids promote cell cycle progression and proliferation of platinum resistant ovarian cancer cells

Abstract 3867: Small molecule inhibitors targeting TG2 in ovarian cancer and identification of drug escape pathways

Abstract 4410: Targeting MEIS2 in platinum resistant ovarian cancer

Abstract 4101: Blood based biomarkers of DNA methylation associated with platinum resistance in high grade serous ovarian cancer

Abstract 7047: Comparative analysis of transcriptomic and immunological profiles in treatment-naïve black and non-Hispanic White women with high-grade serous ovarian cancer

Abstract 2580: Targeting chromatin in ovarian cancer stem cells

Abstract 443: Unsaturated fatty acids promote cell cycle progression and proliferation of platinum resistant ovarian cancer cells

Abstract IA018: Epigenome targeting in ovarian cancer: preclinical models to clinic

Abstract A036: Nanoparticle targeting in platinum-resistant ovarian cancer reveals dual axis of therapeutic vulnerability involving cholesterol uptake and cell redox balance

Abstract CT056: A multicenter, open-label phase 1/2 trial evaluating the safety, tolerability, and efficacy of MORAb-202, a folate-receptor-alpha-targeting antibody-drug conjugate in patients with selected tumor types

Abstract 6068: Methylomic, transcriptomic and immune profiles of high grade serous ovarian cancer among Black and non-Hispanic White women

Abstract 2499: Complement activation at the interface between cancer cells and adipocytes

Abstract 5797: NTX301, a novel DNA hypomethylating agent, targets lipid metabolism in ovarian cancer

Abstract 5811: Ovarian cancer cell fate is regulated by the balance between saturated and unsaturated fatty acids

Abstract 5359: M6A regulated NNMT mediates resistance to platinum in ovarian cancer

Abstract 2978: E2F1 regulates cell competition, increase proliferation and inhibits chemotherapy resistance in cancer cells

Abstract 995: Tissue transglutaminase regulates integrin-linked kinase and beta-catenin signaling in ovarian cancer cells

Abstract 5467: NTX301 targets platinum resistant ovarian cancer

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only